Tesamorelin + Ipamorelin

Tesamorelin + Ipamorelin

$ 53

Tesamorelin is a GHRH analog approved (as Egrifta) for HIV-associated lipodystrophy; here it is paired with ipamorelin, a selective growth hormone secretagogue, for combined GH-axis research.

✓ Synergistic GH release
✓ Targeted visceral fat reduction
✓ Lean muscle gain
✓ Improved sleep quality
✓ Anti-aging metabolic benefits
✓ Ipamorelin minimizes cortisol/prolactin while adding GH pulse
• Fluid retention
• Joint pain
• Injection site reactions
• Headache
• Transient glucose elevation
• Generally well tolerated
Tesamorelin: ~26 min / Ipamorelin: ~2h
FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. for this compounded blend; tesamorelin itself is an approved drug only when obtained via prescription.

Tesamorelin + Ipamorelin

$ 53

Tesamorelin is a GHRH analog approved (as Egrifta) for HIV-associated lipodystrophy; here it is paired with ipamorelin, a selective growth hormone secretagogue, for combined GH-axis research.

FOR LABORATORY / RESEARCH USE ONLY. Not for human use or consumption. Not for animal or veterinary use or testing. Not a drug, food, cosmetic, or medical device, and not evaluated or approved by the FDA. for this compounded blend; tesamorelin itself is an approved drug only when obtained via prescription.
✓ Synergistic GH release
✓ Targeted visceral fat reduction
✓ Lean muscle gain
✓ Improved sleep quality
✓ Anti-aging metabolic benefits
✓ Ipamorelin minimizes cortisol/prolactin while adding GH pulse
Tesamorelin: ~26 min / Ipamorelin: ~2h